Green Line Hospital-Territory Study: A Single-Blind Randomized Clinical Trial for Evaluation of Technological Challenges of Continuous Wireless Monitoring in Internal Medicine, Preliminary Results.
acute medicine
integrating hospital and community
internal medicine core competencies
poly-morbidity
telemedicine
wireless monitoring system
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
30 09 2021
30 09 2021
Historique:
received:
29
07
2021
revised:
28
08
2021
accepted:
24
09
2021
entrez:
13
10
2021
pubmed:
14
10
2021
medline:
26
10
2021
Statut:
epublish
Résumé
Wireless vital parameter continuous monitoring (WVPCM) after discharge is compared to regular monitoring to provide data on the clinical-economic impact of complex patients (CPs) discharged from Internal Medicine Units of Ospedale dei Castelli, Lazio. Major complications (MC) reduction. Patients who reached discharge criteria within the 7th day from admission; difference in MC incidence at the conclusion of the standard telemonitoring/clinical monitoring phase, 5 and 30 days after discharge; and conditions predisposing to MC occurrence. Open label randomized controlled trial with wearable wireless system that creates alerts on portable devices. Continuous glycemic monitoring is performed for patients with diabetes mellitus. There were 110 patients enrolled (mean age: 76.2 years). Comorbidity: Cumulative Illness Rating Scale CIRS-CI (comorbidities index): 3.93, CIRS SI (severity index): 1.93. About 19% scored a BRASS (Blaylock Risk Assessment Screening Score) ≥20 indicating need for discharge planning requiring step-down care. Globally, 48% of patients in the control group had major complications (27 out of 56 patients), in contrast to 22% in the intervention group (12 out of 54 patients). Since WVPCM detects early complications during the post-discharge CPs monitoring, it increases safety and reduces inappropriate access to the Emergency Room, preventing avoidable re-hospitalizations.
Sections du résumé
BACKGROUND
Wireless vital parameter continuous monitoring (WVPCM) after discharge is compared to regular monitoring to provide data on the clinical-economic impact of complex patients (CPs) discharged from Internal Medicine Units of Ospedale dei Castelli, Lazio.
PRIMARY OUTCOME
Major complications (MC) reduction.
SECONDARY OUTCOMES
Patients who reached discharge criteria within the 7th day from admission; difference in MC incidence at the conclusion of the standard telemonitoring/clinical monitoring phase, 5 and 30 days after discharge; and conditions predisposing to MC occurrence.
METHODS
Open label randomized controlled trial with wearable wireless system that creates alerts on portable devices. Continuous glycemic monitoring is performed for patients with diabetes mellitus.
RESULTS
There were 110 patients enrolled (mean age: 76.2 years). Comorbidity: Cumulative Illness Rating Scale CIRS-CI (comorbidities index): 3.93, CIRS SI (severity index): 1.93. About 19% scored a BRASS (Blaylock Risk Assessment Screening Score) ≥20 indicating need for discharge planning requiring step-down care. Globally, 48% of patients in the control group had major complications (27 out of 56 patients), in contrast to 22% in the intervention group (12 out of 54 patients).
CONCLUSIONS
Since WVPCM detects early complications during the post-discharge CPs monitoring, it increases safety and reduces inappropriate access to the Emergency Room, preventing avoidable re-hospitalizations.
Identifiants
pubmed: 34639631
pii: ijerph181910328
doi: 10.3390/ijerph181910328
pmc: PMC8507826
pii:
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Références
J Clin Endocrinol Metab. 2013 Aug;98(8):3411-9
pubmed: 23760624
Resuscitation. 2013 Apr;84(4):465-70
pubmed: 23295778
J Clin Endocrinol Metab. 2018 Mar 1;103(3):1224-1232
pubmed: 29342264
Telemed J E Health. 2019 Jul;25(7):569-583
pubmed: 30124394
Int J Environ Res Public Health. 2021 Jun 03;18(11):
pubmed: 34204972
BMJ Qual Saf. 2013 Dec;22(12):989-97
pubmed: 23828878
Eur J Intern Med. 2007 Jul;18(4):283-7
pubmed: 17574101
Heart Fail Rev. 2020 Mar;25(2):231-243
pubmed: 31197564
Int J Qual Health Care. 2010 Apr;22(2):115-25
pubmed: 20147333
BMJ Open. 2020 Oct 13;10(10):e036904
pubmed: 33051232
Eur J Intern Med. 2015 Dec;26(10):759-65
pubmed: 26365373
Lancet. 2001 Apr 14;357(9263):1191-4
pubmed: 11323066
Ann Surg Oncol. 2007 May;14(5):1532-9
pubmed: 17294075
Epidemiol Prev. 2012 May-Aug;36(3-4):151-61
pubmed: 22828228
Int J Qual Health Care. 2013 Feb;25(1):16-28
pubmed: 23283731
Healthc Policy. 2013 Aug;9(1):76-88
pubmed: 23968676